Cargando…
Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis
BACKGROUND: Pharmacovigilance assesses the safety profile of drugs. Its main aim is the increase of spontaneous reporting of adverse drug reactions (ADRs). The Italian Drug Agency (AIFA; Agenzia Italiana del Farmaco) is financing several projects to the aim of increasing reporting, and in Calabria a...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3697214/ https://www.ncbi.nlm.nih.gov/pubmed/23826016 |
_version_ | 1782275176264630272 |
---|---|
author | Scicchitano, Francesca Giofrè, Chiara Palleria, Caterina Mazzitello, Carmela Ciriaco, Miriam Gallelli, Luca Paletta, Laura Marrazzo, Giuseppina De Fazio, Salvatore Menniti, Michele Curia, Rubens Arena, Concetta Chimirri, Serafina Patanè, Marinella Esposito, Stefania Cilurzo, Felisa Staltari, Orietta Russo, Emilio De Sarro, Giovambattista |
author_facet | Scicchitano, Francesca Giofrè, Chiara Palleria, Caterina Mazzitello, Carmela Ciriaco, Miriam Gallelli, Luca Paletta, Laura Marrazzo, Giuseppina De Fazio, Salvatore Menniti, Michele Curia, Rubens Arena, Concetta Chimirri, Serafina Patanè, Marinella Esposito, Stefania Cilurzo, Felisa Staltari, Orietta Russo, Emilio De Sarro, Giovambattista |
author_sort | Scicchitano, Francesca |
collection | PubMed |
description | BACKGROUND: Pharmacovigilance assesses the safety profile of drugs. Its main aim is the increase of spontaneous reporting of adverse drug reactions (ADRs). The Italian Drug Agency (AIFA; Agenzia Italiana del Farmaco) is financing several projects to the aim of increasing reporting, and in Calabria a Pharmacovigilance Information Centre has been created. MATERIALS AND METHODS: We analyzed the AIFA database relatively to Calabria in the year 2011 and we have analyzed ADRs using descriptive statistics. We have also collected a questionnaire-based interview in order to describe the background knowledge in the field. RESULTS: Regarding the number of AIFA reported ADRs from Calabria, a 38% increase (138 vs. 100) in comparison to 2010 was evidenced. Hospital Doctors represent the main source of signaling (71.7 %). Ketoprofene and the combination amoxicillin/clavulanic acid represent the most frequently reported drugs causing ADRs. Our questionnaires indicated that despite the health professionals have met at least once an ADR only a small percentage of them was reported to the authorities (37%). There is a very good knowledge of the ADR concept and reporting system (90% of interviewed distinguish an ADR and knows how to report it), and there is a strong interest in participating to training courses in the field (95% are interested). CONCLUSIONS: Despite Calabria has had a positive increase in the number of reported ADRs, the total number is very low and the pharmacovigilance culture is far from being achieved in this region. |
format | Online Article Text |
id | pubmed-3697214 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-36972142013-07-03 Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis Scicchitano, Francesca Giofrè, Chiara Palleria, Caterina Mazzitello, Carmela Ciriaco, Miriam Gallelli, Luca Paletta, Laura Marrazzo, Giuseppina De Fazio, Salvatore Menniti, Michele Curia, Rubens Arena, Concetta Chimirri, Serafina Patanè, Marinella Esposito, Stefania Cilurzo, Felisa Staltari, Orietta Russo, Emilio De Sarro, Giovambattista J Res Med Sci Original Article BACKGROUND: Pharmacovigilance assesses the safety profile of drugs. Its main aim is the increase of spontaneous reporting of adverse drug reactions (ADRs). The Italian Drug Agency (AIFA; Agenzia Italiana del Farmaco) is financing several projects to the aim of increasing reporting, and in Calabria a Pharmacovigilance Information Centre has been created. MATERIALS AND METHODS: We analyzed the AIFA database relatively to Calabria in the year 2011 and we have analyzed ADRs using descriptive statistics. We have also collected a questionnaire-based interview in order to describe the background knowledge in the field. RESULTS: Regarding the number of AIFA reported ADRs from Calabria, a 38% increase (138 vs. 100) in comparison to 2010 was evidenced. Hospital Doctors represent the main source of signaling (71.7 %). Ketoprofene and the combination amoxicillin/clavulanic acid represent the most frequently reported drugs causing ADRs. Our questionnaires indicated that despite the health professionals have met at least once an ADR only a small percentage of them was reported to the authorities (37%). There is a very good knowledge of the ADR concept and reporting system (90% of interviewed distinguish an ADR and knows how to report it), and there is a strong interest in participating to training courses in the field (95% are interested). CONCLUSIONS: Despite Calabria has had a positive increase in the number of reported ADRs, the total number is very low and the pharmacovigilance culture is far from being achieved in this region. Medknow Publications & Media Pvt Ltd 2012-09 /pmc/articles/PMC3697214/ /pubmed/23826016 Text en Copyright: © Journal of Research in Medical Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Scicchitano, Francesca Giofrè, Chiara Palleria, Caterina Mazzitello, Carmela Ciriaco, Miriam Gallelli, Luca Paletta, Laura Marrazzo, Giuseppina De Fazio, Salvatore Menniti, Michele Curia, Rubens Arena, Concetta Chimirri, Serafina Patanè, Marinella Esposito, Stefania Cilurzo, Felisa Staltari, Orietta Russo, Emilio De Sarro, Giovambattista Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis |
title | Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis |
title_full | Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis |
title_fullStr | Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis |
title_full_unstemmed | Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis |
title_short | Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis |
title_sort | pharmacovigilance and drug safety 2011 in calabria (italy): adverse events analysis |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3697214/ https://www.ncbi.nlm.nih.gov/pubmed/23826016 |
work_keys_str_mv | AT scicchitanofrancesca pharmacovigilanceanddrugsafety2011incalabriaitalyadverseeventsanalysis AT giofrechiara pharmacovigilanceanddrugsafety2011incalabriaitalyadverseeventsanalysis AT palleriacaterina pharmacovigilanceanddrugsafety2011incalabriaitalyadverseeventsanalysis AT mazzitellocarmela pharmacovigilanceanddrugsafety2011incalabriaitalyadverseeventsanalysis AT ciriacomiriam pharmacovigilanceanddrugsafety2011incalabriaitalyadverseeventsanalysis AT gallelliluca pharmacovigilanceanddrugsafety2011incalabriaitalyadverseeventsanalysis AT palettalaura pharmacovigilanceanddrugsafety2011incalabriaitalyadverseeventsanalysis AT marrazzogiuseppina pharmacovigilanceanddrugsafety2011incalabriaitalyadverseeventsanalysis AT defaziosalvatore pharmacovigilanceanddrugsafety2011incalabriaitalyadverseeventsanalysis AT mennitimichele pharmacovigilanceanddrugsafety2011incalabriaitalyadverseeventsanalysis AT curiarubens pharmacovigilanceanddrugsafety2011incalabriaitalyadverseeventsanalysis AT arenaconcetta pharmacovigilanceanddrugsafety2011incalabriaitalyadverseeventsanalysis AT chimirriserafina pharmacovigilanceanddrugsafety2011incalabriaitalyadverseeventsanalysis AT patanemarinella pharmacovigilanceanddrugsafety2011incalabriaitalyadverseeventsanalysis AT espositostefania pharmacovigilanceanddrugsafety2011incalabriaitalyadverseeventsanalysis AT cilurzofelisa pharmacovigilanceanddrugsafety2011incalabriaitalyadverseeventsanalysis AT staltariorietta pharmacovigilanceanddrugsafety2011incalabriaitalyadverseeventsanalysis AT russoemilio pharmacovigilanceanddrugsafety2011incalabriaitalyadverseeventsanalysis AT desarrogiovambattista pharmacovigilanceanddrugsafety2011incalabriaitalyadverseeventsanalysis |